Celestica CEO Robert Mionis Sells Shares in Planned Move
CEO Robert Mionis sold 18,176 Celestica shares on June 17, 2026, in a planned transaction.
Key Points
- Celestica CEO Robert Mionis sold 18,176 shares on June 17, 2026, at an average price of $385.17, totaling $7 million.
- Celestica trades on the NYSE with a market cap of $43.9 billion and a P/E ratio of 46.3, with recent earnings showing strong revenue growth.
- Analysts maintain a strong buy consensus for Celestica, with a target mean price of $444.11 and multiple firms rating it a buy.
On June 17, 2026, Celestica Inc.'s CEO, Robert Mionis, sold 18,176 shares of the company, according to a planned transaction. The shares were sold at an average price of $385.17, bringing the total transaction value to approximately $7 million.
Insider Buying and Selling at Celestica Inc.
Robert Mionis has been actively selling shares in recent days. On June 17, he sold 18,176 shares, and earlier, on June 16, he sold 55,768 shares at an average price of $386.96. On June 15, he also sold 66,056 shares at $400.06. These transactions were part of a pre-arranged trading plan. Additionally, CFO Mandeep Chawla sold 17,000 shares at $399.65 on June 15. In contrast, insiders Laurette Koellner and Robert Cascella made small purchases in May.
Other Institutional Activity in Celestica
Several institutional investors have adjusted their positions in Celestica. FMR LLC increased its holdings by 149,027 shares, reaching a total of 7,560,325 shares valued at about $2.13 billion. JPMorgan Chase & Co added 433,170 shares, now holding 4,450,793 shares worth roughly $1.15 billion. Vanguard Capital Management LLC made a new position with 3,156,565 shares valued at $890 million. Meanwhile, Franklin Resources Inc. grew its stake by 365,509 shares, totaling 2,643,723 shares worth $745 million. Jane Street Group, LLC significantly boosted its position with 1,437,780 additional shares, while Arrowstreet Capital reduced its stake by 961,872 shares.
Celestica Stock Snapshot
Shares of NYSE:CLS traded near $382.01. Celestica has a market cap of $43.9 billion and a P/E ratio of 46.3. The stock's 52-week range is between $130.68 and $474.03, with a 50-day moving average of $382.81 and a 200-day moving average of $311.46. The company has a current ratio of 1.259 and a quick ratio of 0.698, with a debt-to-equity ratio of 44.881.
Recent Earnings
Celestica reported revenue of $13.79 billion, with a growth rate of 0.528. The company achieved a net margin of 6.95% and a return on equity of 52.45%. Earnings per share stood at $8.25. The next earnings report is scheduled for July 27, 2026.
Analysts Set New Price Targets
On May 1, 2026, Rothschild & Co initiated coverage on Celestica with a buy rating and a $460 price target. On April 29, JP Morgan maintained its buy rating with a $425 target, while UBS held a hold rating with a $400 target. Citigroup, TD Cowen, RBC Capital, Barclays, and Susquehanna all maintained or upgraded their buy ratings, with targets ranging from $415 to $510. The consensus among analysts is a strong buy, with a target mean price of $444.11.
About Celestica
Celestica Inc., headquartered in Toronto, Canada, provides supply chain solutions worldwide. The company operates through segments such as Advanced Technology Solutions and Connectivity and Cloud Solutions. It offers a variety of services including product design, manufacturing, and after-market support. Celestica serves sectors like aerospace, defense, HealthTech, and communications. The company is led by CEO Robert Mionis and employs over 23,800 people.
Bottom Line
Robert Mionis's recent share sales are part of a planned strategy, offering a glimpse into insider activities at Celestica. As a major player in the technology sector, Celestica's stock performance and institutional interest continue to draw attention. With a strong buy consensus from analysts, the company's future developments will be closely watched by investors.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.
